Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Bruno Scheller , Bodo Cremers , Stephanie Schmitmeier , et al Added: 3 years ago
Coronary angioplasty was introduced to clinical practice by Andreas Grüntzig in 1977.1 In the coronary field, the most important improvement in angioplasty has been achieved with the introduction of stents. A significant proportion of the complex modern coronary interventional techniques rely on stenting. Stenting overcomes recoil and dissections but not restenosis due to neointimal proliferation… View more

Intervention
CRT 2019: Safety of Paclitaxel Coated Balloons
Author(s): Marianne Brodmann Added: 5 years ago
Prof Marianne Brodmann (Medical University of Graz, AT) discusses safety of pacilitaxel coated balloons. Filmed on site by Radcliffe Cardiology. Questions: 1.There have been safety concerns with paclitaxel DCB's. What is your take on this? (00:09) 2.Are you still implanting drug coated balloons? (02:16) View more

Intervention
Job title: Senior Consultant Cardiologist and Head of Interventional Cardiology Services
Dr Ho Hee Hwa graduated from the University of Hong Kong in 1997 and completed his cardiology training in Queen Mary Hospital in 2004. He undertook an Interventional Cardiology Fellowship program in 2006 at New York Presbyterian Weill-Cornell Hospital, USA. Dr Ho joined the Department of Cardiology, Tan Tock Seng Hospital, Singapore in 2010. He is currently a Senior Consultant Cardiologist… View more
Job title: Chairman of the Department of Vascular Surgery
Dr Sean Lyden is the Chairman of the Department of Vascular Surgery at Cleveland Clinic’s Sydell and Arnold Miller Family Heart, Vascular & Thoracic Institute. Dr Lyden earned his medical degree from the University of Cincinnati College of Medicine following an undergraduate degree from the University of Notre Dame. He served a residency in general surgery at the University of Tennessee Health… View more
Drug Release Profiles of Different Drug-coated Balloon Platforms
Author(s): Torsten Heilmann , Christian Richter , Heiko Noack , et al Added: 3 years ago
Drug-coated balloons (DCBs) are a nascent technology gaining a lot of attention among cardiologists and angiologists worldwide. As opposed to drug-eluting stents (DES) they allow intraluminal drug application to diseased arterial tissue without leaving an implant such as a metal scaffold behind. This may be beneficial where a stent is already in place or where stenting is problematic due to… View more

Intervention
TCT 21: SCB Shows Similar Angiographic Outcomes to Paclitaxel DCB
Author(s): Bruno Scheller Added: 2 years ago
In this video, Professor Bruno Scheller (Saarland University, Saarbrücken, DE) sits down to discuss the one-year angiographic outcomes of two parallel randomized trials investigating the effectiveness off sirolimus-coated and paclitaxel-coated DCB's in the treatment of coronary in-stent restenosis. Findings suggest comparable outcomes in both devices. Discussion points: 1. Importance of this… View more

Intervention
Complete Revascularisation 2022: On-Demand
CORE 2022

Video Series

Author(s): Jonathan Hill , James Spratt , Charalambos Antoniades , et al Added: 1 year ago
Millbrook Medical Conferences, in association with Abbott and Radcliffe Cardiology, proudly introduce the6thannual CORE meeting, brought to you live and in person from the Royal College of Physicians, London. CORE 2022assembles world renowned experts to discuss and demonstrate how we can optimise PCI outcomes, together as a community. Innovative lectures and live cases address the appropriate… View more

Intervention
EuroPCR 22: SCB with Micro-Reservoir Technology in Coronary Lesions
Author(s): Praveen Chandra Added: 1 year ago
In this short interview, Dr Praveen Chandra (Medanta - The Medicity, IN) shares key findings from the study that looked at the sirolimus-coated balloon with micro-reservoir technology in coronary lesions. The study investigated the SELUTION SLR drug-eluting balloon (MedAlliance) for coronary and peripheral indications. Discussion Points: 1. Study Rationale 2. Micro-reservoir Technology 3. Study… View more

Intervention
CRT 23: Findings From a Sub-Analysis of the EASTBOURNE Trial
Author(s): Bernardo Cortese Added: 1 year ago
CRT 23 - In this short interview, we are joined by Dr Bernardo Cortese (Fondazione Ricerca e InnovazioneCardiovascolare, IT, DCB Academy, IT,Cardio Parc, FR) to outline the findings from a prespecified sub-analysis of the EASTBOURNE study. In this trial, investigators aimed to evaluate the performance of a sirolimus-coated balloon to treat coronary lesions. This sub-analysis collected and… View more

Intervention
ESC 23: The OCTIVUS Study
Author(s): Duk-Woo Park , Do-Yoon Kang Added: 7 months ago
ESC 2023 — We are joined onsite by Dr Duk-Woo Park and Dr Do-Yoon Kang (Asan Medical Center, Seoul, KR) to discuss the findings from the OCTIVUS study (NCT03394079). The OCTIVUS study (Seung-Jung Park, CardioVascular Research Foundation, Korea) aims to compare the clinical safety and efficacy of optimal coherence tomography (OCT) guided and intravascular ultrasound (IVUS) guided strategies in… View more

Intervention